These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Diagnosis of metastasis of malignant melanoma in the thyroid gland with f18-FDG PET scan]. Wolf G; Aigner RM; Schwarz T; Nicoletti R Hautarzt; 2002 May; 53(5):332-3. PubMed ID: 12063745 [TBL] [Abstract][Full Text] [Related]
7. Detection of isolated distant metastasis in soft tissue sarcoma by fluorodeoxyglucose positron emission tomography: case report. Ben Arush MW; Israel O; Kedar Z; Goralnik L; Best LA; Meushar N; Elhasid R; Postovsky S Pediatr Hematol Oncol; 2001 Jun; 18(4):295-8. PubMed ID: 11400656 [TBL] [Abstract][Full Text] [Related]
8. A case of malignant melanoma with cardiac and gallbladder metastases detected by FDG PET-CT. Ozülker T; Ozülker F; Cicin I; Ozpaçac T Clin Nucl Med; 2009 Dec; 34(12):948-9. PubMed ID: 20139846 [No Abstract] [Full Text] [Related]
9. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer. Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493 [TBL] [Abstract][Full Text] [Related]
10. FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid. Wiesner W; Engel H; von Schulthess GK; Krestin GP; Bicik I Eur Radiol; 1999; 9(5):975-8. PubMed ID: 10370003 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET. Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889 [TBL] [Abstract][Full Text] [Related]
12. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374 [TBL] [Abstract][Full Text] [Related]
13. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT. Kato K; Kubota T; Ikeda M; Tadokoro M; Abe S; Nakano S; Nishino M; Kobayashi H; Ishigaki T J Nucl Med; 2006 Mar; 47(3):404-9. PubMed ID: 16513608 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438 [TBL] [Abstract][Full Text] [Related]
15. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Clark PB; Soo V; Kraas J; Shen P; Levine EA Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694 [TBL] [Abstract][Full Text] [Related]
16. Acute toxoplasmosis mimicking melanoma metastases: review of conditions causing false-positive results on (18)F-FDG PET/CT. Ivanova K; Glatz K; Zippelius A; Nicolas G; Itin P Dermatology; 2012; 225(4):349-53. PubMed ID: 23406996 [TBL] [Abstract][Full Text] [Related]
17. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography. Low SC; Sinha AK; Sundram FX Singapore Med J; 2005 Jun; 46(6):304-7. PubMed ID: 15902360 [TBL] [Abstract][Full Text] [Related]
18. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans. Ong SC; Ng DC; Sundram FX Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358 [TBL] [Abstract][Full Text] [Related]
19. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm. Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260 [TBL] [Abstract][Full Text] [Related]
20. Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma. Zuijdwijk MD; Vogel WV; Corstens FH; Oyen WJ Nucl Med Commun; 2008 Jul; 29(7):636-41. PubMed ID: 18528186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]